ClinicalTrials.Veeva

Menu

Relationship Between Malocclusion Severity and Periodontitis Risk

R

Recep Tayyip Erdogan University Training and Research Hospital

Status

Not yet enrolling

Conditions

Malocclusion

Study type

Observational

Funder types

Other

Identifiers

NCT07127744
periortho05/2025

Details and patient eligibility

About

The goal of this observational study is to examine the potential relationship between the severity of orthodontic malocclusion and the risk of developing periodontitis in individuals by evaluating salivary and gingival crevicular levels of RANKL, osteoprotegerin (OPG), and oxidative stress biomarkers.

The main question it aims to answer is:

Does increasing severity of orthodontic malocclusion contribute to a higher risk of periodontitis through changes in RANKL/OPG balance and oxidative stress levels?

Participants with different levels of tooth misalignment (malocclusion) will be examined to assess the condition of their teeth and gums. During this examination, information such as dental plaque, gum bleeding, and the depth of gum pockets will be recorded. In addition, fluid samples collected from the gums will be tested in the laboratory to measure certain biological substances and chemical markers related to the body's balance between harmful and protective effects. These measurements will be done using special laboratory tests.

Full description

The aim of this study is to evaluate the potential relationship between the severity of orthodontic malocclusion and the risk of developing periodontitis through the analysis of RANKL, osteoprotegerin (OPG), and oxidative stress biomarkers. The mechanical effects of malocclusion on teeth and surrounding tissues may lead to inflammation and tissue destruction within the periodontal structures. Understanding the biomolecular mechanisms involved in this process is essential for early diagnosis and preventive approaches.

This cross-sectional study will include individuals with varying degrees of malocclusion severity. Orthodontic status will be determined through clinical evaluation and standardized indices, while periodontal status will be assessed using parameters such as the plaque index, papillary bleeding index, and probing pocket depth. In addition, gingival crevicular fluid (GCF) samples will be collected from participants to measure levels of RANKL, OPG, total antioxidant capacity (TAC), and total oxidative status (TOS) using the ELISA method.

The data obtained will help reveal whether orthodontic abnormalities increase the risk of periodontal disease and how this risk correlates with biomarker levels. The study emphasizes the importance of a holistic evaluation of both orthodontic and periodontal health.

Enrollment

70 estimated patients

Sex

All

Ages

12 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients between the ages of 12 and 18,
  • Patients with all permanent teeth,
  • Not having taken antibiotics, steroids, and/or nonsteroidal anti-inflammatory drugs in the last 3 weeks,
  • Not having an active infectious disease,
  • Not having chronic medication use that affects periodontal tissues (cyclosporine A, Phenytoin),
  • Not having taken antioxidant supplements in the last 6 months.

Exclusion criteria

  • Presence of any congenital craniofacial deformity (cleft lip and palate or any other craniofacial syndrome or deformity),
  • Patients who have previously started or completed orthodontic treatment,
  • Patients who have received periodontal treatment in the last 6 months,
  • Acute illness,
  • Systemic illness, mental illness, immunosuppressive medications, or immunodeficiency.

Trial design

70 participants in 4 patient groups

Patients with normal or minor malocclusion
Description:
Patients with a Dental Aesthetic Index Score of ≤25
Moderate malocclusion
Description:
Patients with a Dental Aesthetic Index Score of 26-30
Severe malocclusion
Description:
Patients with a Dental Aesthetic Index Score of 31-35
Obstructive malocclusion
Description:
Patients with a Dental Aesthetic Index Score ≥ 36

Trial contacts and locations

1

Loading...

Central trial contact

Oguz KOSE, Professor Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems